Adiponectin and its receptor R1 regulate a specific disease modifier, peroxisome proliferator-activated receptor gamma coactivator-1α, which is downregulated in ALS human skeletal muscles [4, 36] and is able to modulate disease onset as well as progression in males [37]. Here, ADIPOQ is linked to amyotrophic lateral sclerosis.